IDEAYA Biosciences, Inc.
- Last sale
- Nov 12, 2026 · -3.76%
- Market cap
- $3.04B
- 96.69M shares
- Filings
- 506
Q3 2026+3,024.4% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+33.7% FY25 yoy
- $3.04B
- —
- 13.9×
- 2.8×
- -2.42%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $218,710,000 | reported | |
| FY 2024 | 2024-12-31 | $7,000,000 | reported | |
| FY 2023 | 2023-12-31 | $23,385,000 | reported | |
| FY 2022 | 2022-12-31 | $50,931,000 | reported | |
| FY 2021 | 2021-12-31 | $27,941,000 | reported | |
| FY 2020 | 2020-12-31 | $19,538,000 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported |
Pharmaceutical preparations
IDEAYA Biosciences, Inc. is the 82nd largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RCUSArcus Biosciences, Inc.$247.0M4.3%142.9%$2.6BKROSKeros Therapeutics, Inc.$244.1M6,775.0%35.7%$197.2MAKBAAkebia Therapeutics, Inc.$236.2M47.5%2.3%$138.5MANABAnaptysbio, Inc$234.6M157.0%5.6%$1.4BPBYIPuma Biotechnology, Inc.$228.4M0.9%13.6%$418.0M
IDYAIDEAYA Biosciences, Inc. (this company)$218.7M3,024.4%52.0%$3.0B
VNDAVanda Pharmaceuticals Inc.$216.1M8.7%102.0%$238.9MAMRNAmarin Corp Plcuk$213.6M6.5%18.2%$4.9BRYTMRhythm Pharmaceuticals, Inc.$189.8M45.8%103.6%$7.6BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR